搜索医生

Ritu Banerjee, M.D., Ph.D.

预约门诊

出版物

  1. Zhang F, Jacob JT, Desai S, Su J, Patel R, Ge L, Banerjee R, Boutzoukas AE, Dai W, Cober E, Abbo LM, Komarow L, Chen L, Hill C, Satlin MJ, Grant M, Fries BC, Patel G, McCarty TP, Arias CA, Bonomo RA, van Duin D, Antibacterial Resistance Leadership Group and the MDRO Network Investigators. Carbapenem-resistant Enterobacterales in solid organ transplant recipients. Am J Transplant. 2024 Nov 8 Epub 2024 Nov 08
    View PubMed
  2. Fortuna GG, Banerjee R, Savid-Frontera C, Song J, Moran-Segura CM, Nguyen JV, Lekakis L, Fernandez-Pol S, Samraj AN, Naresh KN, Vazquez-Martinez M, Baz RC, Spiegel JY, Mikkilineni L, Gubatan JM, Sidana S, de Menezes Silva Corraes A, Kalariya NM, Patel KK, Shim KG, Fonseca R, Ferreri C, Voorhees PM, Richard S, Valdes CR, Sireesha Asoori Asoori, Wolf JL, Cowan AJ, Sborov DW, Locke FL, Lin Y, Wang Y, Hansen DK. Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma. Blood Cancer J. 2024 Oct 16; 14 (1):180
    View PubMed
  3. Banerjee R, Sexton R, Cowan AJ, Rosenberg AS, Ailawadhi S, Rajkumar SV, Kumar SK, Dispenzieri A, Lonial S, Durie BGM, Richardson PG, Usmani SZ, Hoering A, Orlowski RZ. Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis. Blood. 2024 Sep 25 Epub 2024 Sept 25
    View PubMed
  4. Banerjee R, Biru Y, Cole CE, Faiman B, Midha S, Ailawadhi S. Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel. Blood Cancer J. 2024 Aug 27; 14 (1):149
    View PubMed
  5. Hoff FW, Banerjee R, Khan AM, McCaughan G, Wang B, Wang X, Roose J, Anderson LD Jr, Cowan AJ, Rajkumar SV, Kaur G. Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis. Blood Cancer J. 2024 Mar 22; 14 (1):52
    View PubMed
  6. Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B. Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation. Br J Haematol. 2024 Mar; 204 (3):887-891 Epub 2023 Dec 06
    View PubMed
  7. Zhang F, Jacob JT, Desai S, Su J, Banerjee R, Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J, Cober E, Alenazi T, Zong Z, Xie Q, Liu Z, Li L, Yu Y, Gao H, Kanj SS, Figueroa J, Herc E, Cordova E, Weston G, Ananth Tambyah P, Garcia-Diaz J, Kaye KS, Dhar S, Munita JM, Salata RA, Vilchez S, Stryjewski ME, Villegas Botero MV, Iovleva A, Evans SR, Baum K, Hill C, Kreiswirth BN, Patel R, Paterson DL, Arias CA, Bonomo RA, Chambers HF, Fowler VG Jr, Satlin MJ, van Duin D, Doi Y, Multi-Drug Resistant Organism Network Investigators. Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions. Clin Infect Dis. 2024 Feb 17; 78 (2):248-258
    View PubMed
  8. Fisher M, Komarow L, Kahn J, Patel G, Revolinski S, Huskins WC, van Duin D, Banerjee R, Fries BC. Carbapenem-resistant Enterobacterales in Children at 18 US Health Care System Study Sites: Clinical and Molecular Epidemiology From a Prospective Multicenter Cohort Study. Open Forum Infect Dis. 2024 Feb; 11 (2):ofad688 Epub 2024 Jan 08
    View PubMed
  9. Pavlides M, Mozes FE, Akhtar S, Wonders K, Cobbold J, Tunnicliffe EM, Allison M, Godfrey EM, Aithal GP, Francis S, Romero-Gomez M, Castell J, Fernandez-Lizaranzu I, Aller R, Gonzalez RS, Agustin S, Pericas JM, Boursier J, Aube C, Ratziu V, Wagner M, Petta S, Antonucci M, Bugianesi E, Faletti R, Miele L, Geier A, Schattenberg JM, Tilman E, Ekstedt M, Lundberg P, Berzigotti A, Huber AT, Papatheodoridis G, Yki-Jarvinen H, Porthan K, Schneider MJ, Hockings P, Shumbayawonda E, Banerjee R, Pepin K, Kalutkiewicz M, Ehman RL, Trylesinksi A, Coxson HO, Martic M, Yunis C, Tuthill T, Bossuyt PM, Anstee QM, Neubauer S, Harrison S, LITMUS Consortium Investigators. Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol. Contemp Clin Trials. 2023 Nov; 134:107352 Epub 2023 Oct 04
    View PubMed
  10. Sharma S, Ge L, Cunningham S, Banerjee R, Chambers HF, Cross HR, Souli M, Evans SR, Patel R, Fowler VG, Antibacterial Resistance Leadership Group. The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions. Clin Infect Dis. 2023 Oct 16; 77 (Suppl 4):S279-S287
    View PubMed
  11. Hanson KE, Banerjee R, Doernberg SB, Evans SR, Komarow L, Satlin MJ, Schwager N, Simner PJ, Tillekeratne LG, Patel R, Antibacterial Resistance Leadership Group. Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2023 Oct 16; 77 (Suppl 4):S314-S320
    View PubMed
  12. Banerjee R, Cunningham S, Zhang S, Evans SR, Patel R, Hamasaki T, Howard-Anderson J, Kinamon T, King HA, Collyar D, Cross HR, Chambers HF, Fowler VG, Boucher HW, Antibacterial Resistance Leadership Group. The Future Ain't What It Used to Be...Out With the Old...In With the Better: Antibacterial Resistance Leadership Group Innovations. Clin Infect Dis. 2023 Oct 16; 77 (Suppl 4):S321-S330
    View PubMed
  13. Tsang M, Banerjee R, Quiroga D, Idossa D, Schoenbeck KL. Where the Sidewalk Ends: Parenting as a Trainee during COVID-19. Cancer Invest. 2023 Jul; 41 (6):559-567 Epub 2023 June 09
    View PubMed
  14. Banerjee R, Kareff SA, Leyfman Y, Dhawan N, Hammons LR, Desai A, Tsang M, Velazquez AI, Nizam A. Professional Challenges for United States Hematology/Oncology Trainees during COVID-19. Cancer Invest. 2023 Jul; 41 (6):539-547 Epub 2023 Apr 11
    View PubMed
  15. Ragon BK, Shah MV, D'Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, Patel SS, Murthy HS, Nieto Y, Strouse C, Badawy SM, Al Hadidi S, Dholaria B, Aljurf M, Vesole DH, Lee CH, Pawarode A, Gergis U, Miller KC, Holmberg LA, Afrough A, Solh M, Munshi PN, Nishihori T, Anderson LD Jr, Wirk B, Kaur G, Qazilbash MH, Shah N, Kumar SK, Usmani SZ. Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis. Blood Adv. 2023 Jun 27; 7 (12):2746-2757
    View PubMed
  16. Banerjee R, Kelkar AH, Durani U, Anagnostou T, Nishitani M, Mallhi K, Majhail NS, Logan AC. Demographics, Motivations, and Experiences of Participants in Transplantation or Cellular Therapy Fellowships. Transplant Cell Ther. 2023 Jun; 29 (6):394.e1-394.e7 Epub 2023 Mar 17
    View PubMed
  17. Wang Y, Jain P, Locke FL, Maurer MJ, Frank MJ, Munoz JL, Dahiya S, Beitinjaneh AM, Jacobs MT, Mcguirk JP, Vose JM, Goy A, Andreadis C, Hill BT, Dorritie KA, Oluwole OO, Deol A, Paludo J, Shah B, Wang T, Banerjee R, Miklos DB, Rapoport AP, Lekakis L, Ghobadi A, Neelapu SS, Lin Y, Wang ML, Jain MD. Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium. J Clin Oncol. 2023 May 10; 41 (14):2594-2606 Epub 2023 Feb 08
    View PubMed
  18. Bak MTJ, Albeniz E, East JE, Coelho-Prabhu N, Suzuki N, Saito Y, Matsumoto T, Banerjee R, Kaminski MF, Kiesslich R, Coron E, de Vries AC, van der Woude CJ, Bisschops R, Hart AL, Itzkowitz SH, Pioche M, Moons LMG, Oldenburg B. Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study. Gastrointest Endosc. 2023 Apr; 97 (4):767-779.e6 Epub 2022 Dec 09
    View PubMed
  19. Banerjee R, Patel R. Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions. JAC Antimicrob Resist. 2023 Feb; 5 (1):dlad018 Epub 2023 Feb 17
    View PubMed
  20. Wang ME, Felder K, Newland JG, Hersh AL, Rajapakse NS, Willis ZI, Banerjee R, Gerber JS, Schwenk HT, Vaz LE. Pediatric antimicrobial stewardship practices at discharge: A national survey. Infect Control Hosp Epidemiol. 2022 Nov; 43 (11):1686-1688 Epub 2021 July 16
    View PubMed
  21. Kansagra A, Dispenzieri A, Fraser R, Estrada-Merly N, Sidana S, Nishihori T, Hansen DK, Anderson LD Jr, Banerjee R, Bumma N, Dhakal B, Khouri J, Landau H, Lee C, Mian H, Nathan S, Savani B, Kumar S, Qazilbash M, Shah N, D'Souza A. Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma. Blood Adv. 2022 Jul 12; 6 (13):3991-3995
    View PubMed
  22. Ong SWX, Hon PY, Wee SSH, Chia JWZ, Mendis S, Izharuddin E, Lin RJ, Chia PY, Sim RCS, Chen MI, Chow A, Yoong J, Lye DC, Teng CB, Tambyah PA, Banerjee R, Patel R, De PP, Vasoo S. Accuracy of a Rapid Multiplex Polymerase Chain Reaction Plus a Chromogenic Phenotypic Test Algorithm for Detection of Extended-Spectrum beta-Lactamase and Carbapenemase-Producing Gram-Negative Bacilli in Positive Blood Culture Bottles. Clin Infect Dis. 2022 May 30; 74 (10):1850-1854
    View PubMed
  23. Ouchveridze E, Banerjee R, Desai A, Aziz M, Lee-Smith W, Mian H, Berger K, McClune B, Sborov D, Qazilbash M, Kumar S, Mohyuddin GR. Financial toxicity in hematological malignancies: a systematic review. Blood Cancer J. 2022 Apr 22; 12 (4):74
    View PubMed
  24. Vaz LE, Felder KK, Newland JG, Hersh AL, Rajapakse NS, Willis ZI, Banerjee R, Gerber JS, Schwenk HT, Wang ME. A National Survey of Outpatient Parenteral Antibiotic Therapy Practices. J Pediatric Infect Dis Soc. 2022 Mar 24; 11 (3):115-118
    View PubMed
  25. Sidana S, Kumar S, Fraser R, Estrada-Merly N, Giralt S, Agrawal V, Anderson LD Jr, Aljurf M, Banerjee R, Bashey A, Battiwalla M, Beitinjaneh A, Chakraborty R, Chhabra S, Dhakal B, Dholaria B, Hashmi S, Janakiram M, Lee C, Lekakis L, Murthy HS, Parrondo R, Wangjam T, Usmani S, Shah N, Qazilbash M, D'Souza A. Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplant Cell Ther. 2022 Feb; 28 (2):83.e1-83.e9 Epub 2021 Nov 12
    View PubMed
  26. Pasvolsky O, Yeshurun M, Fraser R, Estrada-Merly N, Rozovski U, Shargian-Alon L, Assal A, Banerjee R, Bumma N, Gale RP, Hagen P, Holmberg L, Hossain NM, Lazarus HM, Lee C, Mian H, Miller KC, Nathan S, Nagler A, Nishihori T, Parrondo RD, Patel S, Schroeder MA, Usmani SZ, Wang T, Wirk B, Kumar S, Shah N, Qazilbash MH, D'Souza A. Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplant. 2022 Jan; 57 (1):31-37 Epub 2021 Oct 04
    View PubMed
  27. Banerjee R, Hillerson D, Leung SW, Sorrell VL. ST-Segment Elevation in a Patient With Nausea, Vomiting, and Intracerebral Hemorrhage. JACC Case Rep. 2021 Nov 17; 3 (16):1727-1729
    View PubMed
  28. Perez F, Colindres RV, Wilson BM, Saade E, Jump RLP, Banerjee R, Patel R, Evans SR, Bonomo RA. Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health Administration. Clin Infect Dis. 2021 Oct 5; 73 (7):1231-1238
    View PubMed
  29. Banerjee R, Cunningham SA, Beisken S, Posch AE, Johnston B, Johnson JR, Patel R. Core Genome Multi-Locus Sequence Typing and Prediction of Antimicrobial Susceptibility Using Whole Genome Sequences of Escherichia coli Bloodstream Infection Isolates. Antimicrob Agents Chemother. 2021 Aug 23; AAC0113921 [Epub ahead of print]
    View PubMed
  30. Banerjee R, Komarow L, Virk A, Rajapakse N, Schuetz AN, Dylla B, Earley M, Lok J, Kohner P, Ihde S, Cole N, Hines L, Reed K, Garner OB, Chandrasekaran S, de St Maurice A, Kanatani M, Curello J, Arias R, Swearingen W, Doernberg SB, Patel R. Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN. Clin Infect Dis. 2021 Jul 1; 73 (1):e39-e46
    View PubMed
  31. Rachamalla HK, Bhattacharya S, Ahmad A, Sridharan K, Madamsetty VS, Mondal SK, Wang E, Dutta SK, Jan BL, Jinka S, Chandra Sekhar Jaggarapu MM, Yakati V, Mukhopadhyay D, Alkharfy KM, Banerjee R. Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery. Nanomedicine (Lond). 2021 Apr; 16 (8):641-656 Epub 2021 Mar 26
    View PubMed
  32. Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A, COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021 Mar 30; 11 (3):e048391
    View PubMed
  33. Madamsetty VS, Paulus A, Akhtar S, Manna A, Rachamalla HR, Banerjee R, Mukhopadhyay D, Chanan-Khan A. Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia. Leuk Lymphoma. 2020 Oct; 61 (10):2399-2408 Epub 2020 June 19
    View PubMed
  34. van Duin D, Arias CA, Komarow L, Chen L, Hanson BM, Weston G, Cober E, Garner OB, Jacob JT, Satlin MJ, Fries BC, Garcia-Diaz J, Doi Y, Dhar S, Kaye KS, Earley M, Hujer AM, Hujer KM, Domitrovic TN, Shropshire WC, Dinh A, Manca C, Luterbach CL, Wang M, Paterson DL, Banerjee R, Patel R, Evans S, Hill C, Arias R, Chambers HF, Fowler VG Jr, Kreiswirth BN, Bonomo RA, Multi-Drug Resistant Organism Network Investigators. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. Lancet Infect Dis. 2020 Jun; 20 (6):731-741 Epub 2020 Mar 06
    View PubMed
  35. Ahmad A, Jan BL, Raish M, Rachamalla HKR, Banerjee R, Mukhopadhyay D, Alkharfy KM. Evaluation of the in vivo genotoxicity of liposomal formulation for delivering anticancer estrogenic derivative (ESC8) in a mouse model. Saudi Pharm J. 2019 Jul; 27 (5):637-642 Epub 2019 Mar 11
    View PubMed
  36. Holmberg PJ, Temesgen Z, Banerjee R. Tuberculosis in Children. Pediatr Rev. 2019 Apr; 40 (4):168-178
    View PubMed
  37. Mendis SM, Vasoo S, Johnston BD, Porter SB, Cunningham SA, Menon SR, Teng CB, De PP, Patel R, Johnson JR, Banerjee R. Clinical and Molecular Correlates of Escherichia coli Bloodstream Infection from Two Geographically Diverse Centers in Rochester, Minnesota, and Singapore. Antimicrob Agents Chemother. 2018 Oct; 62 (10) Epub 2018 Sept 24
    View PubMed
  38. Mase A, Ryan S, Mader G, Alvarez A, Armitige L, Chen L, McSherry G, Wilson J, Mase S, Banerjee R. Pediatric tuberculosis consultations across 5 CDC regional tuberculosis training and medical consultation Centers. J Clin Tuberc Other Mycobact Dis. 2018 May; 11:23-27 Epub 2018 Apr 11
    View PubMed
  39. Uzodi AS, Lohse CM, Banerjee R. Risk Factors For and Outcomes of Multidrug-Resistant Escherichia coli Infections in Children. Infect Dis Ther. 2017 Jun; 6 (2):245-257 Epub 2017 Apr 03
    View PubMed
  40. Banerjee R, Humphries R. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae. Virulence. 2017 May 19; 8 (4):427-439 Epub 2016 May 11
    View PubMed
  41. Uzodi AS, Lohse CM, Banerjee R. Population-Based Study of Incidence and Antimicrobial Resistance Patterns of Extraintestinal Escherichia coli Infections in Children in Olmsted County, Minnesota, 2012. Clin Pediatr (Phila). 2017 Apr; 56 (4):389-392 Epub 2016 July 20
    View PubMed
  42. Anderson DJ, Jenkins TC, Evans SR, Harris AD, Weinstein RA, Tamma PD, Han JH, Banerjee R, Patel R, Zaoutis T, Lautenbach E, Stewardship and Infection Control Committeea of the Antibacterial Resistance Leadership Group (ARLG). The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2017 Mar 15; 64 (suppl_1):S36-S40
    View PubMed
  43. Tsalik EL, Petzold E, Kreiswirth BN, Bonomo RA, Banerjee R, Lautenbach E, Evans SR, Hanson KE, Klausner JD, Patel R, and the Diagnostics and Devices Committee//of the Antibacterial Resistance Leadership Group. Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2017 Mar 15; 64 (suppl_1):S41-S47
    View PubMed
  44. Fox GJ, Benedetti A, Cox H, Koh WJ, Viiklepp P, Ahuja S, Pasvol G, Menzies D, Ahuja S, Ashkin D, Avendano M, Banerjee R, Bauer M, Hollm-Delgado MG, Pai M, Shah L, Bayona JN, Becerra M, Burgos M, Centis R, D'Ambrosio L, Migliori GB, Chan ED, Chiang CY, De Lange WCM, Van Altena R, Van Der Werf TS, De Riemer K, Dung NH, Enarson D, Falzon D, Granich RM, Flanagan K, Flood J, Gandhi N, Garcia-Garcia L, Holtz TH, Iseman M, Strand MJ, Jarlsberg LG, Royce S, Keshavjee S, Kim HR, Mitnick CD, Lancaster J, Van Der Walt M, Lange C, Leimane V, Riekstina V, Leung CC, Li J, Narita M, O'Riordan P, Palmero D, Park SK, Pena J, Perez-Guzman C, Ponce-De-Leon A, Sifuentes-Osornio J, Quelapio MID, Tupasi TE, Robert J, Schaaf HS, Seung KJ, Shin SS, Shim TS, Shiraishi Y, Sotgiu G, Tabarsi P, Vargas MH, Westenhouse J, Yew WW, Yim JJ. Group 5 drugs for multidrug-resistant tuberculosis: Individual patient data meta-analysis European Respiratory Journal. 2017; 49: (1)1600993.
  45. Ahmad A, Mondal SK, Jan BL, Mukhopadhyay D, Banerjee R, Alkharfy KM. Quantification of lipid modified estrogenic derivative (ESC8) in rat plasma by LC-MS: application to a pharmacokinetic study. Biomed Chromatogr. 2016 Dec; 30 (12):2024-2030 Epub 2016 July 24
    View PubMed
  46. Banerjee R, Ozenci V, Patel R. Individualized Approaches Are Needed for Optimized Blood Cultures. Clin Infect Dis. 2016 Nov 15; 63 (10):1332-1339 Epub 2016 Aug 23
    View PubMed
  47. Cruz AT, Hersh AL, Starke JR, Beekmann SE, Polgreen PM, Banerjee R. Controversies in tuberculous infection among pediatric infectious disease specialists in North America. Int J Tuberc Lung Dis. 2016 Nov; 20 (11):1463-1468
    View PubMed
  48. Johnson JR, Davis G, Clabots C, Johnston BD, Porter S, DebRoy C, Pomputius W, Ender PT, Cooperstock M, Slater BS, Banerjee R, Miller S, Kisiela D, Sokurenko EV, Aziz M, Price LB. Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis. Open Forum Infect Dis. 2016 Sep; 3 (3):ofw129 Epub 2016 June 16
    View PubMed
  49. Hasassri ME, Boyce TG, Norgan AP, Cunningham SA, Jeraldo PR, Weissman SJ, Patel R, Banerjee R, Pogue JM, Kaye KS. Correction for Hasassri et al., An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase. Antimicrob Agents Chemother. 2016 Aug; 60 (8):5108 Epub 2016 July 22
    View PubMed
  50. Hasassri ME, Boyce TG, Norgan AP, Cunningham SA, Jeraldo PR, Weissman SJ, Patel R, Banerjee R, Pogue JM, Kaye KS. An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase. Antimicrob Agents Chemother. 2016 Jun; 60 (6):3270-5 Epub 2016 May 23
    View PubMed
  51. Mitnick CD, White RA, Lu C, Rodriguez CA, Bayona J, Becerra MC, Burgos M, Centis R, Cohen T, Cox H, D'Ambrosio L, Danilovitz M, Falzon D, Gelmanova IY, Gler MT, Grinsdale JA, Holtz TH, Keshavjee S, Leimane V, Menzies D, Migliori GB, Milstein MB, Mishustin SP, Pagano M, Quelapio MI, Shean K, Shin SS, Tolman AW, Van Der Walt ML, Van Deun A, Viiklepp P, Ahuja SD, Andreev YG, Ashkin D, Avendano M, Banerjee R, Bauer M, Benedetti A, Brand J, Chan ED, Chiang CY, DeRiemer K, Dung NH, Enarson D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Iseman MD, Jarlsberg LG, Kim HR, Koh WJ, Lancaster J, Lange C, De Lange WCM, Leung CC, Li J, Maug AKJ, Narita M, Odendaal R, O'Riordan P, Pai M, Palmero D, Pasvol G, Ponce-De-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shiraishi Y, Sifuentes-Osornio J, Strand MJ, Shaheed PT, Tupasi TE, Van Altena R, Van Der Werf TS, Vargas MH, Westenhouse J, Yew WW, Yim JJ. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method European Respiratory Journal. 2016; 48: (4)1160-70.
  52. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM, Albanese C, Albani D, Albert ML, Aldudo J, Algul H, Alirezaei M, Alloza I, Almasan A, Almonte-Beceril M, Alnemri ES, Alonso C, Altan-Bonnet N, Altieri DC, Alvarez S, Alvarez-Erviti L, Alves S, Amadoro G, Amano A, Amantini C, Ambrosio S, Amelio I, Amer AO, Amessou M, Amon A, An Z, Anania FA, Andersen SU, Andley UP, Andreadi CK, Andrieu-Abadie N, Anel A, Ann DK, Anoopkumar-Dukie S, Antonioli M, Aoki H, Apostolova N, Aquila S, Aquilano K, Araki K, Arama E, Aranda A, Araya J, Arcaro A, Arias E, Arimoto H, Ariosa AR, Armstrong JL, Arnould T, Arsov I, Asanuma K, Askanas V, Asselin E, Atarashi R, Atherton SS, Atkin JD, Attardi LD, Auberger P, Auburger G, Aurelian L, Autelli R, Avagliano L, Avantaggiati ML, Avrahami L, Awale S, Azad N, Bachetti T, Backer JM, Bae DH, Bae JS, Bae ON, Bae SH, Baehrecke EH, Baek SH, Baghdiguian S, Bagniewska-Zadworna A, Bai H, Bai J, Bai XY, Bailly Y, Balaji KN, Balduini W, Ballabio A, Balzan R, Banerjee R, Banhegyi G, Bao H, Barbeau B, Barrachina MD, Barreiro E, Bartel B, Bartolome A, Bassham DC, Bassi MT, Bast RC Jr, Basu A, Batista MT, Batoko H, Battino M, Bauckman K, Baumgarner BL, Bayer KU, Beale R, Beaulieu JF, Beck GR Jr, Becker C, Beckham JD, Bedard PA, Bednarski PJ, Begley TJ, Behl C, Behrends C, Behrens GM, Behrns KE, Bejarano E, Belaid A, Belleudi F, Benard G, Berchem G, Bergamaschi D, Bergami M, Berkhout B, Berliocchi L, Bernard A, Bernard M, Bernassola F, Bertolotti A, Bess AS, Besteiro S, Bettuzzi S, Bhalla S, Bhattacharyya S, Bhutia SK, Biagosch C, Bianchi MW, Biard-Piechaczyk M, Billes V, Bincoletto C, Bingol B, Bird SW, Bitoun M, Bjedov I, Blackstone C, Blanc L, Blanco GA, Blomhoff HK, Boada-Romero E, Bockler S, Boes M, Boesze-Battaglia K, Boise LH, Bolino A, Boman A, Bonaldo P, Bordi M, Bosch J, Botana LM, Botti J, Bou G, Bouche M, Bouchecareilh M, Boucher MJ, Boulton ME, Bouret SG, Boya P, Boyer-Guittaut M, Bozhkov PV, Brady N, et al, Chen CJ, Chen G, Chen P, Chen Q, Chen W, Cooper JM, Dong Z, Fan C, Fernandez-Zapico ME, Fiesel FC, Gao F, Ge L, Guo C, Harris AL, Her C, Hu D, Hu H, Hussain S, Jackson DJ, Jackson WT, Jia L, Jiang H, Jiang H, Jiang Y, Jimenez A, Kim HY, Kim KW, Kim MM, Kumar D, Lee GM, Lee SJ, Lerman LO, Lewis PA, Li F, Liu Y, Lu B, Maeda A, Martin KR, Martinez J, McCormick C, Prince S, Ryan KM, Sanchez AM, Schulze RJ, Sharma S, Sinicrope FA, Sood AK, Springer W, Stevens C, Sun Y, Tang D, Venkatachalam K, Wang G, Wen X, Weyand CM, Wu GS, Xiao H, Xiao J, Xu X, Xu Z, Yu H, Yu Z, Yuan J, Zhang F, Zhang Y, Zhu W. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12 (1):1-222
    View PubMed
  53. Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. Clin Infect Dis. 2015 Oct 1; 61 (7):1071-80 Epub 2015 July 20
    View PubMed
  54. Madigan T, Johnson JR, Clabots C, Johnston BD, Porter SB, Slater BS, Banerjee R. Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli Sequence Type 131. Clin Infect Dis. 2015 Jul 1; 61 (1):e5-12 Epub 2015 Mar 31
    View PubMed
  55. Saleh EA, Schroeder DR, Hanson AC, Banerjee R. Guideline-concordant antibiotic prescribing for pediatric outpatients with otitis media, community-acquired pneumonia, and skin and soft tissue infections in a large multispecialty healthcare system. Clin Res Infect Dis. 2015 Jan 10; 2 (1)
    View PubMed
  56. Madigan T, Teng CB, Koshaish J, Johnson KR, Graner KK, Banerjee R. Optimization of vancomycin dosing in very low-birth-weight preterm neonates. Am J Perinatol. 2015 Jan; 32 (1):83-6 Epub 2014 May 16
    View PubMed
  57. Burgess MJ, Johnson JR, Porter SB, Johnston B, Clabots C, Lahr BD, Uhl JR, Banerjee R. Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli. Open Forum Infect Dis. 2015 Jan; 2 (1):ofv011 Epub 2015 Feb 17
    View PubMed
  58. Thakur RK, Yadav VK, Kumar A, Singh A, Pal K, Hoeppner L, Saha D, Purohit G, Basundra R, Kar A, Halder R, Kumar P, Baral A, Kumar MJ, Baldi A, Vincenzi B, Lorenzon L, Banerjee R, Kumar P, Shridhar V, Mukhopadhyay D, Chowdhury S. Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin. Nucleic Acids Res. 2014 Oct; 42 (18):11589-600 Epub 2014 Sept 23
    View PubMed
  59. Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2014 Sep; 58 (9):4997-5004 Epub 2014 May 27
    View PubMed
  60. Lane MA, Marschall J, Beekmann SE, Polgreen PM, Banerjee R, Hersh AL, Babcock HM. Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians. Infect Control Hosp Epidemiol. 2014 Jul; 35(7):839-44.
    View PubMed
  61. Sadarangani SP, Batdorf R, Buchhalter LC, Mrelashvili A, Banerjee R, Henry NK, Huskins WC, Boyce TG. Clostridium septicum brain abscesses in a premature neonate. Pediatr Infect Dis J. 2014 May; 33: (5)538-40.
    View PubMed
  62. Banerjee R, Beekmann SE, Doby EH, Polgreen PM, Rathore MH, Hersh AL. Outpatient Parenteral Antimicrobial Therapy Practices Among Pediatric Infectious Diseases Consultants: Results of an Emerging Infections Network Survey. J Pediatric Infect Dis Soc. 2014 Mar; 3 (1):85-8 Epub 2013 Jan 27
    View PubMed
  63. Vasoo S, Madigan T, Cunningham SA, Mandrekar JN, Porter SB, Johnston B, Sampathkumar P, Tosh PK, Johnson JR, Patel R, Banerjee R. Prevalence of rectal colonization with multidrug-resistant Enterobacteriaceae among international patients hospitalized at Mayo Clinic, Rochester, Minnesota. Infect Control Hosp Epidemiol. 2014 Feb; 35 (2):182-6
    View PubMed
  64. Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR. Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-beta-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother. 2013 Dec; 57 (12):6385-8 Epub 2013 Sept 30
    View PubMed
  65. Madigan T, Sieve RM, Graner KK, Banerjee R. The effect of age and weight on vancomycin serum trough concentrations in pediatric patients. Pharmacotherapy. 2013 Dec; 33 (12):1264-72 Epub 2013 July 17
    View PubMed
  66. Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, Sokurenko EV, Johnson JR. The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob Agents Chemother. 2013 Dec; 57 (12):5912-7 Epub 2013 Sept 16
    View PubMed
  67. Banerjee R, Strahilevitz J, Johnson JR, Nagwekar PP, Schora DM, Shevrin I, Du H, Peterson LR, Robicsek A. Predictors and molecular epidemiology of community-onset extended-spectrum beta-lactamase-producing Escherichia coli infection in a Midwestern community. Infect Control Hosp Epidemiol. 2013 Sep; 34 (9):947-53 Epub 2013 July 17
    View PubMed
  68. Banerjee R, Fernandez MG, Enthaler N, Graml C, Greenwood-Quaintance KE, Patel R. Combinations of cefoxitin plus other beta-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2013 Jun; 32 (6):827-33 Epub 2013 Jan 23
    View PubMed
  69. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol. 2013 Apr; 34 (4):361-9 Epub 2013 Feb 13
    View PubMed
  70. Madigan T, Banerjee R. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital. Pediatr Infect Dis J. 2013 Apr; 32 (4):346-9
    View PubMed
  71. Falzon D N, B Migliori, G Sotgiu, et al, on behalf of the collaborative group for meta-analysis of individual patient data in MDR-TB. Resistance to fluoroquinolones and second-line injectable drugs: impact on MDR-TB outcomes. Eur Resp J 156-68. 2013; 42:156-68.
  72. Banerjee R, S E Beekmann, E H Doby, P M Polgreen, M H Rathore, A L Hersh. Outpatient parenteral antimicrobial therapy (OPAT) an Emerging Infections Network survey. J Ped Infect Dis. 2013:1-4.
  73. Swami SK, Banerjee R. Comparison of hospital-wide and age and location - stratified antibiograms of S. aureus, E. coli, and S. pneumoniae: Age- and location-stratified antibiograms. SpringerPlus. 2013; 2(1):1-5.
    View PubMed
  74. Tamma PD, Newland JG, Pannaraj PS, Metjian TA, Banerjee R, Gerber JS, Weissman SJ, Beekmann SE, Polgreen PM, Hersh AL. The use of intravenous colistin among children in the United States: results from a multicenter, case series. Pediatr Infect Dis J. 2013 Jan; 32(1):17-22.
    View PubMed
  75. Newland JG, Banerjee R, Gerber JS, Hersh AL, Steinke L, Weissman SJ. Antimicrobial stewardship in pediatric care: strategies and future directions. Pharmacotherapy. 2012 Aug; 32(8):735-43.
    View PubMed
  76. Swami SK, Liesinger JT, Shah N, Baddour LM, Banerjee R. Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota. Mayo Clin Proc. 2012 Aug; 87(8):753-9. Epub 2012 Jul 13.
    View PubMed
  77. Levy ER, Swami S, Dubois SG, Wendt R, Banerjee R. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010. Infect Control Hosp Epidemiol. 2012 Apr; 33(4):346-53.
    View PubMed
  78. Nienaber JH, McNamara DR, Banerjee R, Pritt BS, Karre T, Sohail MR. Fulminant gestational hepatitis due to primary herpes simplex type 2 infection: use of serum HSV polymerase chain reaction for noninvasive diagnosis. Diagn Microbiol Infect Dis. 2012 Feb; 72 (2):181-4 Epub 2011 Nov 21
    View PubMed
  79. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Pena J, Perez-Guzman C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ, Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012; 9(8):e1001300. Epub 2012 Aug 28.
    View PubMed
  80. Santillan Salas CF, Joshi AY, Dhiman N, Banerjee R, Huskins WC, Wengenack NL, Henry NK. Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis. J Med Microbiol. 2011 Dec; 60 (Pt 12):1869-1871 Epub 2011 July 28
    View PubMed
  81. Banerjee R, Hersh AL, Newland J, Beekmann SE, Polgreen PM, Bender J, Shaw J, Copelovitch L, Kaplan BS, Shah SS, Emerging Infections Network Hemolytic-Uremic Syndrome Study Group. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J. 2011 Sep; 30(9):736-9.
    View PubMed
  82. Sinha S, Roy S, Reddy BS, Pal K, Sudhakar G, Iyer S, Dutta S, Wang E, Vohra PK, Roy KR, Reddanna P, Mukhopadhyay D, Banerjee R. A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis. Mol Cancer Res. 2011 Mar; 9 (3):364-74 Epub 2011 Feb 02
    View PubMed
  83. Banerjee R, Gretes M, Harlem C, Basuino L, Chambers HF. A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level beta-lactam resistance contains mutations in three genes. Antimicrob Agents Chemother. 2010 Nov; 54 (11):4900-2 Epub 2010 Aug 30
    View PubMed
  84. Banerjee R, Allen J, Lin SY, Westenhouse J, Desmond E, Schecter GF, Scott C, Raftery A, Mase S, Watt JP, Flood J. Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California. J Clin Microbiol. 2010 Oct; 48 (10):3779-81 Epub 2010 Aug 11
    View PubMed
  85. Rigelman-Hedberg NE, Bjur KA, Banerjee R, Fischer PR. Staphylococcal toxic shock syndrome due to umbilical piercing Journal of Pediatric Infectious Diseases. 2010; 5: (4)401-3.
  86. Mukherjee A, Narayan KP, Pal K, Kumar JM, Rangaraj N, Kalivendi SV, Banerjee R. Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor. Mol Ther. 2009 Apr; 17 (4):623-31 Epub 2009 Feb 17
    View PubMed
  87. Camarillo D, Banerjee R, Greenhow TL, Tureen JH. Group B streptococcal endocarditis after elective abortion in an adolescent. Pediatr Infect Dis J. 2009 Jan; 28(1):67-9.
    View PubMed
  88. Banerjee R, Schecter GF, Flood J, Porco TC. Extensively drug-resistant tuberculosis: new strains, new challenges. Expert Rev Anti Infect Ther. 2008 Oct; 6(5):713-24.
    View PubMed
  89. Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J. Extensively drug-resistant tuberculosis in california, 1993-2006. Clin Infect Dis. 2008 Aug 15; 47(4):450-7.
    View PubMed
  90. Banerjee R, Gretes M, Basuino L, Strynadka N, Chambers HF. In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2008 Jun; 52(6):2089-96. Epub 2008 Mar 31.
    View PubMed
  91. Drew ME, Banerjee R, Uffman EW, Gilbertson S, Rosenthal PJ, Goldberg DE. Plasmodium food vacuole plasmepsins are activated by falcipains. J Biol Chem. 2008 May 9; 283(19):12870-6. Epub 2008 Feb 28.
    View PubMed
  92. Lee MJ, Pal K, Tasaki T, Roy S, Jiang Y, An JY, Banerjee R, Kwon YT. Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway. Proc Natl Acad Sci U S A. 2008 Jan 8; 105 (1):100-5 Epub 2007 Dec 27
    View PubMed
  93. Freeman JL, Adeniyi A, Banerjee R, Dallaire S, Maguire SF, Chi J, Ng BL, Zepeda C, Scott CE, Humphray S, Rogers J, Zhou Y, Zon LI, Carter NP, Yang F, Lee C. Definition of the zebrafish genome using flow cytometry and cytogenetic mapping. BMC Genomics. 2007 Jun 27; 8:195 Epub 2007 June 27
    View PubMed
  94. Zhang W, Braun A, Bauman Z, Olteanu H, Madzelan P, Banerjee R. Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines. Cancer Res. 2005 Feb 15; 65 (4):1554-60
    View PubMed
  95. Leal NA, Olteanu H, Banerjee R, Bobik TA. Human ATP:Cob(I)alamin adenosyltransferase and its interaction with methionine synthase reductase. J Biol Chem. 2004 Nov 12; 279 (46):47536-42 Epub 2004 Aug 30
    View PubMed
  96. Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Charnitsky VA, Deth RC. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry. 2004 Apr; 9 (4):358-70
    View PubMed
  97. Olteanu H, Wolthers KR, Munro AW, Scrutton NS, Banerjee R. Kinetic and thermodynamic characterization of the common polymorphic variants of human methionine synthase reductase. Biochemistry. 2004 Feb 24; 43 (7):1988-97
    View PubMed
  98. Olteanu H, Banerjee R. Redundancy in the pathway for redox regulation of mammalian methionine synthase: reductive activation by the dual flavoprotein, novel reductase 1. J Biol Chem. 2003 Oct 3; 278 (40):38310-4 Epub 2003 July 18
    View PubMed
  99. Banerjee R, Francis SE, Goldberg DE. Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum. Mol Biochem Parasitol. 2003 Jul; 129(2):157-65.
    View PubMed
  100. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry. 2002 Nov 12; 41 (45):13378-85
    View PubMed
  101. Perry A, Banerjee R, Lohse CM, Kleinschmidt-DeMasters BK, Scheithauer BW. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol. 2002 Apr; 12 (2):183-90
    View PubMed
  102. Banerjee R, Liu J, Beatty W, Pelosof L, Klemba M, Goldberg DE. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci U S A. 2002 Jan 22; 99(2):990-5. Epub 2002 Jan 08.
    View PubMed
  103. Gulati S, Brody LC, Banerjee R. Posttranscriptional regulation of mammalian methionine synthase by B12. Biochem Biophys Res Commun. 1999 Jun 7; 259 (2):436-42
    View PubMed
  104. Le Bonniec S, Deregnaucourt C, Redeker V, Banerjee R, Grellier P, Goldberg DE, Schrevel J. Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. J Biol Chem. 1999 May 14; 274(20):14218-23.
    View PubMed
  105. Fiskerstrand T, Riedel B, Ueland PM, Seetharam B, Pezacka EH, Gulati S, Bose S, Banerjee R, Berge RK, Refsum H. Disruption of a regulatory system involving cobalamin distribution and function in a methionine-dependent human glioma cell line. J Biol Chem. 1998 Aug 7; 273 (32):20180-4
    View PubMed
  106. Mamoun CB, Sullivan DJ Jr, Banerjee R, Goldberg DE. Identification and characterization of an unusual double serine/threonine protein phosphatase 2C in the malaria parasite Plasmodium falciparum. J Biol Chem. 1998 May 1; 273(18):11241-7.
    View PubMed
  107. Gulati S, Chen Z, Brody LC, Rosenblatt DS, Banerjee R. Defects in auxiliary redox proteins lead to functional methionine synthase deficiency. J Biol Chem. 1997 Aug 1; 272 (31):19171-5
    View PubMed
  108. Francis SE, Banerjee R, Goldberg DE. Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II. J Biol Chem. 1997 Jun 6; 272(23):14961-8.
    View PubMed
  109. Banerjee R, Chen Z, Gulati S. Methionine synthase from pig liver. Methods Enzymol. 1997; 281:189-96
    View PubMed
  110. Li YN, Gulati S, Baker PJ, Brody LC, Banerjee R, Kruger WD. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet. 1996 Dec; 5 (12):1851-8
    View PubMed
  111. Gulati S, Baker P, Li YN, Fowler B, Kruger W, Brody LC, Banerjee R. Defects in human methionine synthase in cblG patients. Hum Mol Genet. 1996 Dec; 5 (12):1859-65
    View PubMed
  112. Chen Z, Crippen K, Gulati S, Banerjee R. Purification and kinetic mechanism of a mammalian methionine synthase from pig liver. J Biol Chem. 1994 Nov 4; 269 (44):27193-7
    View PubMed
PST-20225717